GarryFre writes: Neurological researchers at Rush University Medical Center have found a new therapeutic target that can potentially lead to a new way to prevent the progression of Alzheimer's disease. The target called neutral sphingomyelinase (N-SMase) is a protein that when activated, can cause a chain of reactions in the cell leading to neuronal death and memory loss. Already a substance has been found that shows some promise in halting the progression of the disease.

This discussion was created for logged-in users only, but now has been archived.
No new comments can be posted.